Literature DB >> 21421339

Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic.

Adam Oskowitz1, Harris McFerrin, Miriam Gutschow, Mary Leita Carter, Radhika Pochampally.   

Abstract

Recent reports have indicated that mesenchymal stromal cells (MSCs) from bone marrow have a potential in vascular remodeling and angiogenesis. Here, we report a unique phenomenon that under serum-deprived conditions MSCs survive and replicate. Secretome analysis of MSCs grown under serum-deprived conditions (SD-MSCs) identified a significant upregulation of prosurvival and angiogenic factors including VEGF-A, ANGPTs, IGF-1, and HGF. An ex vivo rat aortic assay demonstrated longer neovascular sprouts generated from rat aortic rings cultured in SD-MSC-conditioned media compared to neovascular sprouts from aortas grown in MSC-conditioned media. With prolonged serum deprivation, a subpopulation of SD-MSCs began to exhibit an endothelial phenotype. This population expressed endothelial-specific proteins including VEGFR2, Tie2/TEK, PECAM/CD31, and eNOS and also demonstrated the ability to uptake acetylated LDL. SD-MSCs also exhibited enhanced microtubule formation in an in vitro angiogenesis assay. Modified chick chorioallantoic membrane (CAM) angiogenesis assays showed significantly higher angiogenic potential for SD-MSCs compared to MSCs. Analysis of CAMs grown with SD-MSCs identified human-specific CD31-positive cells in vascular structures. We conclude that under the stress of serum deprivation MSCs are highly angiogenic and a population of these cells has the potential to differentiate into endothelial-like cells.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421339      PMCID: PMC4920087          DOI: 10.1016/j.scr.2011.01.004

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  32 in total

1.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Authors:  Massimiliano Gnecchi; Huamei He; Olin D Liang; Luis G Melo; Fulvio Morello; Hui Mu; Nicolas Noiseux; Lunan Zhang; Richard E Pratt; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

3.  A functional genomics approach to the mode of action of apratoxin A.

Authors:  Hendrik Luesch; Sumit K Chanda; R Marina Raya; Paul D DeJesus; Anthony P Orth; John R Walker; Juan Carlos Izpisúa Belmonte; Peter G Schultz
Journal:  Nat Chem Biol       Date:  2006-02-12       Impact factor: 15.040

Review 4.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

5.  Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction.

Authors:  Ryo Matsumoto; Takashi Omura; Minoru Yoshiyama; Tetsuya Hayashi; Sakiko Inamoto; Ki-Ryang Koh; Kensuke Ohta; Yasukatsu Izumi; Yasuhiro Nakamura; Kaname Akioka; Yasushi Kitaura; Kazuhide Takeuchi; Junichi Yoshikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-14       Impact factor: 8.311

6.  Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.

Authors:  M Aoki; R Morishita; Y Taniyama; I Kida; A Moriguchi; K Matsumoto; T Nakamura; Y Kaneda; J Higaki; T Ogihara
Journal:  Gene Ther       Date:  2000-03       Impact factor: 5.250

7.  Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model.

Authors:  Abdulaziz Al-Khaldi; Hilal Al-Sabti; Jacques Galipeau; Kevin Lachapelle
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

8.  Angiopoietin-1 promotes functional neovascularization that relieves ischemia by improving regional reperfusion in a swine chronic myocardial ischemia model.

Authors:  Winston S N Shim; Wei Li; Li Zhang; Shiqi Li; Hwee Choo Ong; In-Chin Song; Akanksha Bapna; Ruowen Ge; Yean Teng Lim; Seng Chye Chuah; Eugene K W Sim; Philip Wong
Journal:  J Biomed Sci       Date:  2006-03-18       Impact factor: 8.410

9.  Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes.

Authors:  Radhika R Pochampally; Jason R Smith; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

10.  Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages.

Authors:  S I Nishikawa; S Nishikawa; M Hirashima; N Matsuyoshi; H Kodama
Journal:  Development       Date:  1998-05       Impact factor: 6.868

View more
  57 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

2.  Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence.

Authors:  Jiaqiang Ren; David F Stroncek; Yingdong Zhao; Ping Jin; Luciano Castiello; Sara Civini; Huan Wang; Ji Feng; Katherine Tran; Sergei A Kuznetsov; Pamela G Robey; Marianna Sabatino
Journal:  Stem Cell Res       Date:  2013-07-27       Impact factor: 2.020

Review 3.  Systems biology approach to developing S(2)RM-based "systems therapeutics" and naturally induced pluripotent stem cells.

Authors:  Greg Maguire; Peter Friedman
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

4.  Functions of Mesenchymal Stem Cells in Cardiac Repair.

Authors:  Selçuk Öztürk; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Juxtacrine and paracrine interactions of rat marrow-derived mesenchymal stem cells, muscle-derived satellite cells, and neonatal cardiomyocytes with endothelial cells in angiogenesis dynamics.

Authors:  Reza Rahbarghazi; Seyed Mahdi Nassiri; Parvaneh Khazraiinia; Abdol-Mohammad Kajbafzadeh; Seyed Hossein Ahmadi; Elham Mohammadi; Mohammad Molazem; Mohamad Zamani-Ahmadmahmudi
Journal:  Stem Cells Dev       Date:  2012-12-12       Impact factor: 3.272

Review 6.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

7.  Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effects.

Authors:  Yun Lin; Johnathon D Anderson; Lily M A Rahnama; Shenwen V Gu; Anne A Knowlton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-09-28       Impact factor: 4.733

8.  Secretomes from mesenchymal stem cells participate in the regulation of osteoclastogenesis in vitro.

Authors:  Kenichi Ogata; Wataru Katagiri; Hideharu Hibi
Journal:  Clin Oral Investig       Date:  2016-10-29       Impact factor: 3.573

9.  A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease.

Authors:  Shin-Seok Yang; Na-Ri Kim; Kwang-Bo Park; Young-Soo Do; Kyounghwan Roh; Kyung-Sun Kang; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

10.  Reduced serum and hypoxic culture conditions enhance the osteogenic potential of human mesenchymal stem cells.

Authors:  Bernard Y K Binder; John E Sagun; J Kent Leach
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.